MIR29A Impedes Metastatic Behaviors in Hepatocellular Carcinoma via Targeting LOX, LOXL2, and VEGFA

Primary liver cancer accounts for the third most deadly type of malignant tumor globally, and approximately 80% of the cases are hepatocellular carcinoma (HCC), which highly relies on the activity of hypoxia responsive pathways to bolster its metastatic behaviors. MicroRNA-29a (MIR29A) has been show...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ya-Ling, Tsai, Ming-Chao, Chang, Yen-Hsiang, Wang, Chen-Chen, Chu, Pei-Yi, Lin, Hung-Yu, Huang, Ying-Hsien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199573/
https://www.ncbi.nlm.nih.gov/pubmed/34206143
http://dx.doi.org/10.3390/ijms22116001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199573/
https://www.ncbi.nlm.nih.gov/pubmed/34206143
http://dx.doi.org/10.3390/ijms22116001

Ejemplares similares